Ottesen S S, Kieler J, Christensen B
Fibiger Institute, Copenhagen, Denmark.
Eur J Cancer Clin Oncol. 1987 Jul;23(7):991-5. doi: 10.1016/0277-5379(87)90347-6.
The immortalized but non-tumourigenic and non-invasive human urothelial cell line, Hu 609, known to express the appropriate HLA A,B antigens (A2,-; B5,-) has previously been demonstrated to undergo "spontaneous" in vitro transformation into an invasive and tumourigenic subline, Hu 609T/MV. This subline does not express the polymorphic HLA epitopes. In the present investigation we have followed two additional "spontaneous" transformations of the Hu 609 cell line into malignant sublines. Evidence is presented that the development of morphological changes and tumourigenicity were accompanied by a gradual loss of the expression of polymorphic HLA A,B epitopes and a reduction in the expression of monomorphic HLA A,B,C antigens. Antigens could be detected again after neuraminidase treatment. We conclude that the urothelial Hu 609 cell line after "spontaneous" transformation still possesses the HLA A,B epitopes. The observed quantitative differences in HLA expression between Hu 609 and its malignant sublines may be due to masking of the HLA antigens by sialic acid containing tumour-associated highly branched glycoproteins.
永生化但无致瘤性和非侵袭性的人尿路上皮细胞系Hu 609,已知表达适当的HLA A、B抗原(A2,-;B5,-),先前已被证明可在体外“自发”转化为侵袭性和致瘤性子系Hu 609T/MV。该子系不表达多态性HLA表位。在本研究中,我们追踪了Hu 609细胞系另外两次“自发”转化为恶性子系的过程。有证据表明,形态学变化和致瘤性的发展伴随着多态性HLA A、B表位表达的逐渐丧失以及单态性HLA A、B、C抗原表达的减少。神经氨酸酶处理后可再次检测到抗原。我们得出结论,“自发”转化后的尿路上皮Hu 609细胞系仍具有HLA A、B表位。Hu 609与其恶性子系之间观察到的HLA表达定量差异可能是由于含有唾液酸的肿瘤相关高度分支糖蛋白对HLA抗原的掩盖。